# 内源性动静脉瘘设备市场

> EndoAVF设备市场研究报告按类型（外周EndoAVF设备、中央EndoAVF设备、混合EndoAVF设备）、按应用（血液透析、移植、肿瘤学）、按最终用户（医院、门诊手术中心、透析中心）、按程序类型（择期手术、紧急手术、门诊手术）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.04%
- **2024:** $ 0.99 Billion
- **2025:** $ 1.05 Billion
- **2035:** $ 1.89 Billion
- **Key Players:** Endologix (US), Medtronic (US), Boston Scientific (US), Terumo Corporation (JP), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Teleflex Incorporated (US), Cook Medical (US), Cardinal Health (US)

**Report ID:** MRFR/HC/36826-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/endoavf-device-market-38805

---

## Market Summary

## **EndoAVF Device Market Overview**

As per MRFR analysis, the EndoAVF Device Market Size was estimated at 0.99 (USD Billion) in 2024. The EndoAVF Device Market Industry is expected to grow from 1.05 (USD Billion) in 2025 to 1.78 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 6.04% during the forecast period (2025 - 2034).

### **Key EndoAVF Device Market Trends Highlighted**

The EndoAVF Device Market is largely driven by the increasing prevalence of chronic kidney disease and the growing number of patients requiring hemodialysis. As healthcare providers look for efficient solutions, the focus shifts towards improving patient outcomes through advanced technologies in vascular access. The rising awareness about the benefits of endovascular arteriovenous fistulas compared to traditional methods is also fueling market growth. Technological advancements and innovations in medical devices are making these procedures more accessible and safer for patients, which in turn supports broader market expansion. There are numerous opportunities to be explored within this market.

As research continues to evolve, manufacturers can tap into the potential for developing next-generation devices that enhance functionality and adaptability to various patient needs. Collaborations among medical device companies, healthcare providers, and research institutions can lead to innovative solutions. Enhanced education and awareness programs can also create more informed patients who understand their options for vascular access.

The growing emphasis on patient-centric approaches in healthcare opens the avenue for personalized solutions in endoAVF devices. Recently, trends in this market indicate a shift towards minimally invasive techniques and greater incorporation of robotic and digital technologies.The increasing integration of telemedicine is also changing how patients manage their conditions, allowing for remote follow-ups and monitoring, thereby enhancing overall care.

The growing demand for home-based therapies specifically within nephrology, is encouraging further innovation in endoAVF devices. As the healthcare landscape changes, these trends signal a move towards more flexible and patient-friendly solutions that meet the evolving needs of chronic disease management.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **EndoAVF Device Market Drivers**

### Increasing Prevalence of Chronic Kidney Diseases

Significant growth rates are observed in the EndoAVF Device Market Industry owing to the increasing number of chronic kidney disease (CKD) cases across the globe. There is an increasing number of CKD patients who are diagnosed, and because of this, a greater need for effective treatment is witnessed, more so in cases where the administrating hemodialysis requires repeated access to blood vessels. These endoAVF devices address the major challenge of the creation of arteriovenous fistulas in a robust and patient friendly manner.

In addition, the elderly segment is likely to report an increased prevalence of CKD, and this has made the old population a more critical factor. Indeed, with developing healthcare infrastructure and growing awareness related to the issues of the kidney, endoAVF devices are being utilized by health care services. This shift in trend is likely to positively influence the growth of the EndoAVF Device Market Industry as it provides new solutions that meet the demand of patients undergoing dialysis for longer periods of time and also eliminates many problems of conventional vascular access methods.

### Technological Advancements in Medical Devices

Technological advancements are driving the EndoAVF Device Market Industry forward, with innovations leading to the development of more effective and user-friendly devices. Continuous research and development efforts have given rise to next-generation endoAVF devices featuring enhanced biocompatibility and reduced surgical risks. These advancements make procedures smoother and improve patient outcomes, thereby increasing their acceptance among physicians and patients alike.Enhanced imaging techniques also allow for better procedural precision, further driving the adoption of endoAVF devices.

### Government Initiatives and Support for Kidney Health

Government initiatives aimed at promoting kidney health and offering better healthcare access contribute significantly to the growth of the EndoAVF Device Market Industry. Many countries are implementing programs focused on dialysis treatment and preventive healthcare measures for CKD. By providing favorable reimbursement policies and funding for research on effective treatment methods, these initiatives encourage healthcare facilities to invest in advanced endoAVF devices, ultimately benefiting patients in need of vascular access for dialysis.

## **EndoAVF Device Market Segment Insights**

### **EndoAVF Device Market Type Insights**

The EndoAVF Device Market reveals a nuanced landscape segmented by Type, showcasing the framework essential to comprehending market dynamics. In the year 2023, the market is valued at 0.89 USD Billion, reflecting a burgeoning interest in endovascular access for arteriovenous fistulas. The segmentation of this market primarily encompasses Peripheral EndoAVF Devices, Central EndoAVF Devices, and Hybrid EndoAVF Devices, each contributing uniquely to the overall valuation and growth trajectory.

The Peripheral EndoAVF Devices hold significant ground in this arena, with a valuation of 0.34 USD Billion in 2023 and anticipated growth leading to a valuation of 0.57 USD Billion by 2032, representing a majority holding within the market.

Its relevance lies in its broad applications in vascular access for hemodialysis, catering to an ever-increasing patient population with end-stage renal disease. Following closely, Central EndoAVF Devices maintain a substantial foothold, valued at 0.30 USD Billion in 2023, with projections reaching 0.51 USD Billion by 2032. These devices are vital due to their effectiveness in providing stable vascular access, underlining their significance in complex clinical scenarios.

Meanwhile, Hybrid EndoAVF Devices, although currently the smallest segment valued at 0.25 USD Billion in 2023, are expected to grow to 0.42 USD Billion by 2032.This growth signals a rising interest in technologies that combine different methodologies to optimize patient care. Analyzing these dynamics not only presents a clear picture of the EndoAVF Device Market revenue distribution but also illustrates the underlying trends and drivers of market growth, such as technology advancement, an aging population, and an increase in chronic diseases.

The interplay of these segments reflects a broader industry shift towards more effective and accessible treatment options poised to meet increasing healthcare demands globally.Thus, the market statistics underscore opportunities for innovation within these segments, driving future research and development.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **EndoAVF Device Market Application Insights  **

The EndoAVF Device Market in 2023 was valued at 0.89 billion USD, demonstrating robust growth potential in the application segment, which includes Hemodialysis, Transplantation, and Oncology. Among these applications, Hemodialysis remains a vital area due to the increasing prevalence of chronic kidney diseases, necessitating the development and use of reliable vascular access devices. Transplantation has emerged as a significant segment as advancements in techniques and technologies enhance patient outcomes, making it a preferred choice for end-stage renal disease management.

Oncology also plays a crucial role as the demand for vascular access devices increases to support chemotherapy treatments. The EndoAVF Device Market segmentation indicates a diverse landscape that caters to various medical needs, reflecting the critical nature of these applications in modern healthcare. As the market evolves, drivers like technological advancements and a growing patient population will shape trends, while challenges such as regulatory hurdles and competition may necessitate continued innovation. Together, these factors contribute to a dynamic and growing market with significant opportunities for development across all applications.

### **EndoAVF Device Market End User Insights  **

The EndoAVF Device Market, valued at 0.89 billion USD in 2023, is witnessing significant growth influenced by its diverse End User segment. This market is primarily segmented into key areas including hospitals, ambulatory surgical centers, and dialysis centers, each playing a crucial role in the adoption and utilization of EndoAVF devices. Hospitals dominate this segment, benefiting from advanced infrastructure and specialized staff, which facilitates complex vascular access procedures.

Ambulatory surgical centers are emerging as essential alternatives, offering efficient outpatient services that align with the growing trend toward minimally invasive surgical practices.Dialysis centers are also pivotal as they require reliable vascular access solutions for patients. The increasing prevalence of renal diseases and the rising demand for effective dialysis treatments further enhance the significance of dialysis centers within this market.

The EndoAVF Device Market data suggests that each of these End Users contributes to the market growth by addressing specific healthcare needs and improving patient outcomes, thus providing opportunities to innovate and expand their services. Moreover, market trends reveal a steady shift towards integrated treatment solutions, which are anticipated to bolster the overall market dynamics in the coming years.

### **EndoAVF Device Market Procedure Type Insights  **

The EndoAVF Device Market is forecasted to reach a valuation of 0.89 billion USD in 2023, reflecting steady demand in the healthcare sector. Within this market, the Procedure Type segment is a crucial area of focus, consisting of various categories. Elective Procedures are often noted for their planned nature and play a key role in enhancing patient quality of life, hence driving the market growth.

Emergency Procedures address critical situations and underline the medical urgency in utilizing EndoAVF devices. Outpatient Procedures, which facilitate shorter hospital stays, are gaining traction due to their efficiency and convenience, presenting significant opportunities for market expansion.The collective growth of these categories shapes the overall dynamics of the EndoAVF Device Market, with each type serving distinct patient needs and clinical requirements.

As the market evolves, understanding the EndoAVF Device Market segmentation will be vital for stakeholders aiming to capture market share and address the varying demands of healthcare providers and patients. Overall, these segments contribute actively to the EndoAVF Device Market revenue and are instrumental in meeting the rising demand for innovative vascular access solutions.

### **EndoAVF Device Market Regional Insights  **

The EndoAVF Device Market demonstrates significant regional segmentation, where in 2023, North America holds the majority with a valuation of 0.45 USD Billion, projected to rise to 0.75 USD Billion by 2032. This dominance is attributed to advanced healthcare infrastructure and a higher adoption rate of innovative medical devices. Europe follows, with a market value of 0.25 USD Billion in 2023, increasing to 0.4 USD Billion by 2032, driven by a growing geriatric population and increasing awareness about vascular access solutions.

The APAC region, valued at 0.12 USD Billion in 2023, is anticipated to exhibit robust growth as healthcare investments rise, with projections reaching 0.22 USD Billion by 2032.South America's market is smaller at 0.05 USD Billion in 2023, expected to grow to 0.08 USD Billion, reflecting its emerging healthcare landscape. Lastly, the MEA region, valued at 0.02 USD Billion in 2023, is limited but holds growth potential as healthcare systems develop, projected to reach 0.05 USD Billion by 2032.

Overall, the EndoAVF Device Market illustrates diverse opportunities across regional markets, fueled by varying healthcare dynamics and growing demand for effective vascular access solutions.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **EndoAVF Device Market Key Players and Competitive Insights**

The EndoAVF Device Market is experiencing significant growth driven by advancements in medical technology and an increasing demand for minimally invasive vascular access solutions. This sector is characterized by intense competition among notable manufacturers and innovative startups who are striving to enhance patient outcomes and streamline procedural efficiency. The competitive landscape features a variety of companies that are focused on developing sophisticated devices aimed at facilitating the creation of endovenous arteriovenous fistulas.

As the market matures, factors such as product innovation, regulatory compliance, and strategic partnerships are becoming pivotal in shaping the competitive dynamics. Key players are increasingly investing in research and development to foster technological advancements while navigating the complexities of regulatory approvals across various regions.Terumo Corporation has established a strong presence in the EndoAVF Device Market, recognized for its commitment to quality and innovation. The company leverages its extensive experience in the medical device industry to offer a range of endoAVF products that are designed to improve patient safety and procedural effectiveness.

With a robust research and development framework, Terumo Corporation continually seeks to enhance its offerings, integrating cutting-edge technologies that cater to the evolving needs of healthcare providers. The company's strategic collaborations and partnerships further bolster its market position, enabling it to access diverse distribution channels. Its strong focus on customer relationships ensures that it remains responsive to the requirements of medical professionals and patients alike, thereby solidifying its role as a leader in the endoAVF device market.Stryker is also a key player in the EndoAVF Device Market, known for its focus on medical innovation and high-quality healthcare products.

The company has a wide array of solutions specifically designed to enhance vascular access and improve clinical outcomes. Stryker invests heavily in technology and product development, allowing for advancements that address the complexities of endovenous procedures. The company’s extensive global reach enables it to cater to diverse healthcare markets, ensuring availability and access to its devices across multiple regions. Strong customer support services and training programs further enhance Stryker's reputation among healthcare professionals. The commitment to improving patient outcomes through innovative design and effective solutions positions Stryker as a formidable competitor within the endoAVF device sector.

## **Key Companies in the EndoAVF Device Market Include**

- Terumo Corporation
- Stryker
- Hologic
- Smith and  Nephew
- Cardinal Health
- Teleflex
- Baxter International
- Medline Industries
- AngioDynamics
- Cook Medical
- Bard Medical
- Abbot Laboratories
- Boston Scientific
- **[Medtronic](https://www.medtronic.com/en-us/healthcare-professionals/products.html)**
- Johnson and  Johnson

## **EndoAVF Device Market Industry Developments**

The EndoAVF Device Market has seen noteworthy developments recently, particularly with major companies like Terumo Corporation, Stryker, and Hologic continuing to advance their technologies. Innovations are being introduced that enhance the efficacy of EndoAVF procedures, allowing for better patient outcomes. Companies such as Smith and Nephew and Bard Medical are increasing their presence by launching new products aimed at improving vascular access. In terms of mergers and acquisitions, there have been strategic alignments involving firms like Medtronic and Boston Scientific, indicating a trend toward consolidation to amplify market capabilities and distribution networks.

Furthermore, financial growth is evident within the sector, with an increased market valuation for key players like Baxter International and Teleflex, which is driving further investment and research in endovascular technologies. This surge in market activity is reflective of a broader trend toward minimally invasive procedures, promoting a competitive landscape among companies seeking to capture market share in the EndoAVF device arena. As such, these developments and financial trajectories are shaping the future landscape of the EndoAVF Device Market.

## **EndoAVF Device Market Segmentation Insights**

### **EndoAVF Device Market Type Outlook**

- Peripheral EndoAVF Devices
- Central EndoAVF Devices
- Hybrid EndoAVF Devices

### **EndoAVF Device Market Application Outlook**

- Hemodialysis
- [Transplantation](../../../reports/transplantation-market-11866)
- Oncology

### **EndoAVF Device Market End User Outlook**

- Hospitals
- Ambulatory Surgical Centers
- Dialysis Centers

### **EndoAVF Device Market Procedure Type Outlook**

- Elective Procedures
- Emergency Procedures
- Outpatient Procedures

### **EndoAVF Device Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### 技术进步

EndoAVF设备市场正在经历技术进步的激增，这些进步提高了血管通路程序的有效性和安全性。诸如微创技术和改进的成像技术等创新正在改变内血管动静脉瘘的创建方式。例如，利用超声引导的设备正变得越来越普遍，允许更精确的放置并减少并发症。预计市场在未来五年内将以约12%的年复合增长率（CAGR）增长，这一增长受到这些进步的推动。此外，人工智能在设备设计中的整合可能会优化患者的结果，使程序更快、更可靠。随着医疗服务提供者寻求采用最新技术，EndoAVF设备市场有望实现显著增长。

### 监管焦点

监管机构对内源性动静脉瘘（EndoAVF）设备市场的重视程度不断提高，这正在影响市场动态。为了确保血管内设备的安全性和有效性，正在制定更严格的法规和指导方针。这种监管关注可能会导致审批过程中的审查力度加大，这可能会在初期减缓新产品的推出。然而，这也鼓励制造商投资于研发，以满足这些标准。结果是市场上提供的产品更加稳健和可靠。随着合规性成为一个关键因素，能够有效应对这些监管环境的公司预计将获得竞争优势。这一不断变化的监管环境预计将显著影响内源性动静脉瘘设备市场的未来。

### 提高意识和教育

对血管通路选择的认识和教育正在显著影响内源性动静脉瘘（EndoAVF）设备市场。医疗专业人员和患者对内血管动静脉瘘相较于传统方法的优势变得越来越了解。教育倡议和培训项目正在实施，以增强对这些设备的理解，从而改善患者的结果。随着意识的提高，更多患者可能会倡导内源性动静脉瘘手术，从而推动需求。此外，医疗提供者也意识到教育其员工掌握最新技术和方法的重要性，这对成功实施至关重要。这一趋势预计将促进更为知情的患者群体，最终有助于内源性动静脉瘘设备市场的扩展，因为它与患者和医疗提供者不断变化的需求相一致。

### 不断增长的患者群体

EndoAVF设备市场正在增长，主要受到需要血管通路解决方案的患者人数增加的推动。慢性肾病的流行以及接受透析的患者数量上升都在促进这一趋势。根据最近的统计数据，到2026年，接受透析的患者数量预计将达到500万，造成对有效血管通路设备的巨大需求。这一不断增长的患者基础促使医疗服务提供者寻求创新解决方案，从而扩大EndoAVF设备的市场。此外，随着对血管内手术益处的认识增加，更多患者可能会选择这些微创选项。因此，EndoAVF设备市场在适应不断扩大的患者群体需求的同时，正处于持续增长的有利位置。

### 增加对医疗保健的投资

医疗基础设施的投资是EndoAVF设备市场的关键驱动因素。各国政府和私人实体正在投入大量资源以改善医疗设施和提高患者护理。这一趋势在医疗系统正在发展以满足老龄化人口需求的地区尤为明显。增加的资金正在促进先进医疗技术的采用，包括EndoAVF设备，这对于有效的血管通路至关重要。随着医疗服务提供者升级他们的设施和设备，对创新解决方案的需求可能会增加。此外，科技公司与医疗服务提供者之间的合作变得越来越普遍，促进了尖端设备的发展。这一投资的涌入预计将推动EndoAVF设备市场向前发展，创造增长和创新的机会。

## Future Outlook

内源性动静脉瘘（EndoAVF）设备市场预计将在2024年至2035年间以6.04%的年复合增长率增长，推动因素包括技术进步、血管疾病的日益普遍以及对微创手术的需求上升。

**New opportunities:**

- 开发集成远程医疗平台以进行远程监测和支持。

到2035年，EndoAVF设备市场预计将实现显著增长和创新。

## Segment Insights

### 按类型：外周内瘘设备（最大）与中央内瘘设备（增长最快）

在 EndoAVF 设备市场中，外周 EndoAVF 设备占据了市场份额的重要部分，使其成为最大的细分市场。它们的广泛采用主要是由于其在增强需要透析的患者血管通路方面的有效性。与此同时，中央 EndoAVF 设备正在快速增长，这得益于技术的进步和对微创手术日益增长的需求。由于中央设备能够提供更好的结果和更低的并发症发生率，因此在临床环境中受到青睐。
EndoAVF 设备市场的增长通常受到终末期肾病发病率上升和需要透析的患者数量增加的影响。随着医疗服务提供者旨在提升患者护理，向中央设备的过渡正在加速，因为它们可以简化程序并改善恢复时间。外周设备将继续占主导地位，但由于技术创新和支持其在不同患者群体中使用的良好临床结果，中央设备正在迅速追赶。

外周内瘘设备（主导）与中央内瘘设备（新兴）

外周内瘘设备的特点在于能够直接在患者的肢体上创建血管通路，促进更好的血流，使其成为透析治疗中的重要设备。其综合设计最小化了与传统通路方法相关的并发症，并为医疗提供者提供了额外的便利。另一方面，中央内瘘设备因其能够通过更少的外科干预提供增强的通路而在市场上越来越受到重视。对微创技术的日益重视使中央设备成为一种新兴的替代方案，吸引了临床医生和患者，使其成为现代血管通路协议中的可行选择。

### 按应用：血液透析（最大）与移植（增长最快）

在EndoAVF设备市场中，应用细分展示了其关键关注领域之间市场份额的多样分布，特别是血液透析、移植和肿瘤学。血液透析作为最大的细分市场，因其在肾衰竭患者管理中的关键作用，推动了市场的可观份额。相比之下，移植细分市场正在迅速获得关注，得益于移植技术的创新和器官移植程序的日益普及。

血液透析（主导）与移植（新兴）

血液透析在内瘘血管通路设备市场中占据主导地位，原因在于慢性肾病的高发病率以及对有效透析解决方案的相应需求。围绕血液透析治疗建立的强大基础设施和协议确保了其持续的普及。另一方面，移植领域则代表了一个新兴的增长领域。随着医疗技术的进步，器官移植的效率和成功率正在提高，导致其采用率上升。这一增长得到了对器官捐献的日益关注和接受的进一步支持，使移植成为未来市场发展的关键参与者。

### 按最终用户：医院（最大）与透析中心（增长最快）

EndoAVF设备市场在主要终端用户细分中展示了多样化的分布，医院因其全面的基础设施和高频的手术量而占据了重要份额。门诊手术中心（ASC）作为一个显著的细分市场，提供门诊手术和创新的护理模式，而透析中心则迅速崛起为市场中的关键用户，响应日益增加的慢性肾病患者对先进血管通路解决方案的需求。

透析中心（新兴）与医院（主导）

医院在内瘘设备市场中仍然占据主导地位，受益于丰富的资源、熟练的人员和广泛的医疗服务。他们将先进技术整合到患者护理中的能力有助于获得更大的市场份额。相比之下，透析中心作为一个关键细分市场正在崛起，受到对专业肾脏护理需求上升的推动。这些中心专注于透析治疗，增加了对高效血管通路的需求。它们的增长受到人口变化和透析程序进步的推动，使其成为满足慢性肾病患者独特需求的关键参与者。

### 按程序类型：择期手术（最大）与紧急手术（增长最快）

EndoAVF设备市场在其手术类型中显示出明确的市场份额分布，其中选择性手术由于其计划性和对微创手术选项日益增长的偏好而占据最大份额。紧急手术虽然份额较小，但由于紧急响应技术的进步和在关键情况下快速干预的需求，正在获得关注。门诊手术虽然重要，但由于门诊护理的可及性差异和患者对舒适和在家恢复的偏好，维持较小的份额。

选择性手术（主导）与紧急手术（新兴）

选择性手术主导了内血管通路设备市场，重点关注患者的便利性和治疗效果，使医疗服务提供者能够在最佳时机安排手术。这些手术由于其选择性特征，需求稳定，满足寻求高质量护理的患者，而不受紧急病例的压力。相反，紧急手术正在迅速崛起，受到技术进步和对紧急医疗情况下立即血管通路需求增长的推动。该细分市场的特点是迅速的行动和创新的技术，增强了患者的生存和恢复，标志着内血管通路领域的重要趋势。

## Regional Market Share Analysis

### 北美：创新的市场领导者

北美是EndoAVF设备最大的市场，占全球市场份额的约45%。该地区的增长受到终末期肾病发病率增加、医疗技术进步和支持性监管框架的推动。对微创手术的需求也在上升，进一步推动市场增长。像FDA这样的监管机构简化了审批流程，增强了市场动态。美国是该市场的主要贡献者，主要参与者包括美敦力、波士顿科学和雅培实验室，主导着竞争格局。先进的医疗基础设施和高额的医疗支出支持了EndoAVF设备的增长。加拿大也发挥着重要作用，通过不断增长的医疗投资和日益提高的患者意识为整体市场做出贡献。

### 欧洲：具有监管的新兴市场

欧洲是EndoAVF设备第二大市场，占全球市场份额的约30%。该地区的增长受到老龄化人口、慢性肾病发病率上升和医疗投资增加的推动。像欧洲药品管理局（EMA）这样的监管机构积极推动医疗设备的创新，预计将增强市场的可及性和增长。以患者为中心的医疗解决方案的关注也是一个重要驱动因素。该地区的主要国家包括德国、法国和英国，这些国家的医疗系统越来越多地采用先进的医疗技术。像B. Braun Melsungen AG和Terumo Corporation这样的主要参与者在这些市场中已建立良好基础。竞争格局的特点是合作与伙伴关系，旨在增强产品供应和扩大市场覆盖，确保EndoAVF设备的强劲增长轨迹。

### 亚太地区：快速增长与采用

亚太地区的EndoAVF设备市场正在迅速增长，占全球市场份额的约20%。该地区的扩展受到医疗支出增加、患者人口增长和对先进医疗技术认识提高的推动。日本和中国等国在这一增长中处于领先地位，得益于政府旨在改善医疗基础设施和获取创新治疗的举措。对微创手术的需求也在上升，进一步增强了市场潜力。日本在该市场中脱颖而出，特鲁莫公司等企业做出了重要贡献。竞争格局正在演变，本地制造商与已建立的全球参与者共同崛起。该地区对技术进步和患者护理的关注预计将推动EndoAVF设备市场的进一步增长，使其成为投资和发展的关键领域。

### 中东和非洲：医疗保健中的未开发潜力

中东和非洲地区在EndoAVF设备市场中逐渐崭露头角，占全球市场份额的约5%。增长主要受到医疗投资增加、对慢性疾病认识提高和对先进医疗技术需求的推动。南非和阿联酋等国的政府正专注于改善医疗基础设施，预计将为市场扩展创造机会。该地区多样化的医疗需求为增长提供了独特的环境。南非是该市场的关键参与者，越来越多的医疗设施采用先进的医疗技术。竞争格局的特点是本地和国际参与者的混合，像Cook Medical和Cardinal Health等公司正在取得显著进展。随着医疗系统的发展，对EndoAVF设备的需求预计将上升，为该地区的利益相关者提供丰厚的机会。

## Competitive Benchmarking

EndoAVF设备市场目前的特点是动态的竞争格局，受到技术进步和对微创手术需求增加的驱动。Endologix（美国）、美敦力（美国）和波士顿科学（美国）等主要参与者处于前沿，各自采取不同的策略来增强市场存在感。Endologix（美国）专注于创新，特别是在开发下一代血管内设备方面，而美敦力（美国）则强调战略合作伙伴关系，以扩展其产品供应。波士顿科学（美国）积极追求并购，以增强其产品组合，表明市场上出现了整合趋势。这些策略共同促成了一个既创新又快速发展的竞争环境。

在商业策略方面，公司越来越多地本地化生产，以降低成本并提高供应链效率。这种方法在EndoAVF设备市场中尤为相关，该市场适度分散，多个参与者争夺市场份额。这些主要参与者的集体影响塑造了市场结构，因为他们利用自身的运营优势来获得竞争优势。对供应链优化和本地化生产的关注可能会增强对市场需求和监管要求的响应能力。

2025年8月，Endologix（美国）宣布推出其最新的血管内设备，该设备集成了先进的成像技术，以改善手术结果。这一战略举措不仅强化了Endologix对创新的承诺，还使公司能够捕获日益增长的对复杂血管解决方案的需求。预计该设备的推出将改善患者结果并简化手术程序，从而巩固Endologix的竞争优势。

2025年9月，美敦力（美国）与一家领先的远程医疗提供商达成战略合作伙伴关系，以增强其EndoAVF设备的远程患者监测能力。这一合作表明美敦力对数字化转型的关注，旨在通过技术改善患者参与度和结果。通过整合远程医疗解决方案，美敦力可能会增强其服务供应，从而在竞争激烈的市场中实现差异化。

2025年7月，波士顿科学（美国）完成了对一家专注于创新血管技术的小型医疗设备公司的收购。这一收购是波士顿科学扩展产品组合和增强其在EndoAVF设备市场竞争定位的战略举措。新技术的整合预计将推动增长和创新，使波士顿科学能够更好地满足医疗服务提供者和患者不断变化的需求。

截至2025年10月，EndoAVF设备市场正在见证数字化、可持续性和人工智能在产品开发中整合等趋势。战略联盟越来越多地塑造竞争格局，使公司能够利用互补优势并增强市场供应。展望未来，竞争差异化可能会从传统的基于价格的竞争转向对创新、技术进步和供应链可靠性的关注。这一转变强调了在快速变化的市场中保持竞争优势的适应能力和前瞻性战略的重要性。

## Recent News & Developments

EndoAVF设备市场最近出现了显著的发展，特别是像Terumo Corporation、Stryker和Hologic等主要公司继续推进他们的技术。正在引入的创新提高了EndoAVF手术的有效性，使患者的结果更好。像Smith and Nephew和Bard Medical这样的公司通过推出旨在改善血管通路的新产品来增加他们的市场份额。在并购方面，涉及Medtronic和Boston Scientific等公司的战略联盟表明，市场能力和分销网络的整合趋势正在加剧。

此外，行业内的财务增长显而易见，Baxter International和Teleflex等关键参与者的市场估值增加，推动了对血管内技术的进一步投资和研究。这一市场活动的激增反映了向微创手术的更广泛趋势，促进了公司之间在EndoAVF设备领域争夺市场份额的竞争格局。因此，这些发展和财务轨迹正在塑造EndoAVF设备市场的未来格局。

## Report Scope

| 2024年市场规模 | 0.9897（十亿美元） |
| --- | --- |
| 2025年市场规模 | 1.05（十亿美元） |
| 2035年市场规模 | 1.887（十亿美元） |
| 年复合增长率（CAGR） | 6.04%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 微创技术的进步提高了EndoAVF设备市场的患者结果。 |
| 主要市场动态 | 技术进步和监管变化推动了EndoAVF设备市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，EndoAVF设备市场的预计市场估值是多少？**
A: 预计到2035年，内源性动静脉瘘（EndoAVF）设备市场的估值将达到18.87亿美元。

**Q: 2024年EndoAVF设备市场的市场估值是多少？**
A: 在2024年，EndoAVF设备市场的市场估值为9.897亿美元。

**Q: 2025年至2035年，EndoAVF设备市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，EndoAVF设备市场的预期CAGR为6.04%。

**Q: 在内瘘血管通路设备市场中，哪些公司被视为关键参与者？**
A: EndoAVF设备市场的主要参与者包括Endologix、Medtronic、Boston Scientific和Abbott Laboratories。

**Q: EndoAVF设备市场的主要细分领域是什么？**
A: EndoAVF设备市场的主要细分包括外周、中央和混合EndoAVF设备。

**Q: 2024年到2035年，外周EndoAVF设备的估值是如何变化的？**
A: 外周内瘘装置的估值从2024年的0.3948亿美元增加到2035年预计的0.7435亿美元。

**Q: 哪些应用正在推动内瘘血管通路设备市场的增长？**
A: 推动增长的应用包括血液透析、移植和肿瘤学，其中血液透析的估值在2024年从0.49485亿美元增加。

**Q: 在内瘘血管通路设备市场中，门诊手术中心的预期市场表现如何？**
A: 预计到2035年，门诊手术中心的估值将从2024年的2.961亿美元增加到5.545亿美元。

**Q: 在EndoAVF设备市场中，最常见的程序类型有哪些？**
A: 在EndoAVF设备市场中，常见的手术类型包括择期手术、紧急手术和门诊手术。

**Q: 中央内瘘装置的市场与其他细分市场相比如何？**
A: 中央内瘘设备市场预计将从2024年的2.961亿美元增长到2035年的5.545亿美元，显示出强劲的增长。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/endoavf-device-market-38805*